However, RAGE is either not expressed in non-small cell lung cancer (NSCLC) tissues or its expression is significantly reduced compared with that in normal lungs, leading to reduced RAGE levels, which contribute to the impairment of cells, differentiation, as well as arrangement of the epithelial structure, with associated oncogenic transformation. This evidence concerns the gene AGER and non-small cell lung carcinoma.